Bibliographic Details
| Title: |
Rare ZMPSTE24 variants increase risk of hypertriglyceridemia and metabolic syndrome. |
| Authors: |
Collen, Lauriane Le, Desgrouas, Camille, Croisier, Céline Lukas, Creugnet, Brunot, Dechaume, Aurélie, Toussaint, Bénédicte, Vaillant, Emmanuel, Amanzougarene, Souhila, Falay, Emmanuel Buse, Derhourhi, Mehdi, Lourdelle, Alexandre, Delemer, Brigitte, Bonello-Palot, Nathalie, Vaxillaire, Martine, Badens, Catherine, Froguel, Philippe, Bonnefond, Amélie |
| Source: |
European Journal of Endocrinology; Mar2025, Vol. 192 Issue 3, p240-247, 8p |
| Subject Terms: |
HYPERTRIGLYCERIDEMIA, METABOLIC syndrome, DYSLIPIDEMIA, GENES, LIPODYSTROPHY, FUNCTIONAL assessment, GENETIC variation |
| Abstract: |
Objective The global increase in the prevalence of metabolic syndrome represents a significant public health concern. Rare biallelic pathogenic variants in ZMPSTE24 have been identified as the cause of mandibuloacral dysplasia type B, ie, a lipodystrophy syndrome associated with metabolic complications. The role of monoallelic pathogenic variants in ZMPSTE24 concerning metabolic syndrome remains uncertain. Design Case report and systematic review of literature. Methods We investigated a Wallisian family with FPLD and metabolic syndrome via whole-exome sequencing. We performed functional analyses of an identified rare ZMPSTE24 variant. To broadly assess the effect of heterozygous pathogenic ZMPSTE24 variants on FPLD-associated phenotypes, and metabolic syndrome, we used the Human Gene Mutation Database (HGMD) and 200 K exome data from UK Biobank. Results We investigated a Wallisian family where a 40-year-old female with metabolic syndrome was found to carry a rare heterozygous missense variant in ZMPSTE24. Functional assays showed a decreased prelamin to lamin A maturation and accelerated senescence. In silico analysis demonstrated that this variant might disrupt the lamin A binding site. We then analyzed the impact of monoallelic pathogenic ZMPSTE24 variants on metabolic traits using data from the HGMD and the UK Biobank. In HGMD, ZMPSTE24 variants carriers presented with dyslipidemia and hepatic steatosis. In the UK Biobank, monoallelic pathogenic variants were associated with an increased risk of hypertriglyceridemia, with a trend toward metabolic syndrome. Conclusions This study underscores the association of ZMPSTE24 rare variants with metabolic disorders and emphasizes the need for further research to clarify their clinical implications. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Journal of Endocrinology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
